-
Join leaders from
@AveXisInc,@bluebirdbio,@spark_tx, and@timmermanreport as they discuss how to overcome challenges in delivering on the promise of gene therapy at#WHCBC2020.#genetherapy Get your ticket today at https://whcbc2020.ticketleap.com/newfrontiers/ pic.twitter.com/cz5smA0bI7
-
Was a pleasure hearing about all the exciting things happening
@MarsonLab@UCSF@parkerici#CRISPR#genetherapy#CARTcells -
.
@KrystalBiotech breaks ground on its second commercial#genetherapy facility in Findlay Township, PA: http://ow.ly/Sok850yeGBh pic.twitter.com/J43dj7VUrH
-
We are just 3 days away from the Emerging Cellular Therapies: Cancer and Beyond and Engineering the Genome joint meetings in Banff, Canada! Are you attending? Be sure to set up a meeting with us to learn about our viral vector technologies.
#viralvectors#genetherapy#CARTpic.twitter.com/i82nfDlKpG
-
For most of his 39 years, Charles lived with extreme pain caused by
#sicklecell disease, which dramatically reduced blood flow throughout his body. But thanks to the#genetherapy therapy he received in 2017, he is now symptom-free.#conquerSCD http://bit.ly/2S1GPYU pic.twitter.com/FZMuXq4qgB
-
Did you know there are more than 400 active and recruiting clinical trials in
#GeneTherapy and#CellTherapy across the U.S.? You can search them using our Clinical Trials Finder, which is updated daily. https://bit.ly/2vb3fOd pic.twitter.com/VHyVspyyR1
-
The FDA released final guidance on developing human
#genetherapy products- for adult and pediatric patients with retinal disorders. Read more: http://bit.ly/2OdOpNX pic.twitter.com/uU7EmR66vk
-
.
@KrystalBiotech Breaks Ground on Second#GeneTherapy Facility: http://ow.ly/Sok850yeGBh pic.twitter.com/hDkJYif1Hl
-
More from
#HemOnc Times: Novel Approach Provides#GeneTherapy for Sickle Cell Disease http://ow.ly/Trqm50yc9DM#health#medtwitter#wednesdaymotivation via@BostonChildrenspic.twitter.com/8uoKoekhws
-
AVROBIO is growing! Join us as we strive to take
#genetherapy mainstream for people with genetic disease - see opportunities here: http://bit.ly/2mfG3ds#GoAVROpic.twitter.com/0vAf7h1NiZ
-
Next week,
$ABEO will update results in AAV programs at the WORLDSymposium™ on Lysosomal Storage Diseases. Look forward to finally hearing an update on AAV#GeneTherapy programs.#WORLDSymposia#MPSIIIA#MPSIIIB#CLN1#CLN3#Fabry -
Maryland Biotech
@VigeneBio Opens New#GeneTherapy Contract Manufacturing Facility To Support Rapid Growth http://ow.ly/Q3Hh30qfgwt pic.twitter.com/RFNgmnfyzR
-
Dr. Sowmya Viswanathan's
#webinar is coming up on Feb. 20th! If you're interested in learning how to navigate the New Substance Notification Regulations for Organisms, register at our website: https://cellcan.com/221/Webinar_Series.cellcan …@UHN_Research#NSNRO#CellTherapy#GeneTherapy pic.twitter.com/toDEUadlNV
-
As
#EAHAD2020 marks a golden age of treatment choice, learn all about#genetherapy and non-factor replacement#therapies for#hemophilia in 2 new WFH eLearning modules. An excellent knowledge foundation for HCPs#education http://ow.ly/h9hS50ya6eu pic.twitter.com/pZPaIaRzPv
-
A big week! Vineti announced the close of our
#SeriesC round of $35 million which will support our continued expansion in#EU and#APAC, providing a global solution to industrialize#celltherapy#genetherapy in clinical through to commercial stage. https://buff.ly/2v6k39n pic.twitter.com/kz5ZdpoSvo
-
#CODA#Biotherapeutics acquires#Attenua + clinical-stage assets vs#neuropathic#pain, focal#epilepsy & other#neurological conditions To advance leads using#GeneTherapy-mediated#chemogenetic platform https://www.codabiotherapeutics.com/platform#neurosciences#IonChannelspic.twitter.com/BOyAb5VRbC
-
Gene Circuits Empower Next-Generation Cell and Gene Therapies: Senti Biosciences describes how “living drugs” may be programmed to fulfill user-defined functions http://bit.ly/2GYLKU2
#celltherapy#genetherapy@timlu@SentiBio#synbio -
Intense 1 day workshop on paying for
#GeneTherapy +#CellTherapy March 10th at MIT. This is targeted for#PatientAdvocates,#Insurers,#HealthcareAnalysts and#Pharma. https://www.payingforcures.org/workshop2020/
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.